Authors:
SKLARIN NT
LATHIA CD
BENSON L
GROVE WR
THOMAS S
ROCA J
EINZIG AI
WIERNIK PH
Citation: Nt. Sklarin et al., A PHASE-I TRIAL AND PHARMACOKINETIC EVALUATION OF CI-980 IN PATIENTS WITH ADVANCED SOLID TUMORS, Investigational new drugs, 15(3), 1997, pp. 235-246
Authors:
BASELGA J
TRIPATHY D
MENDELSOHN J
BAUGHMAN S
BENZ CC
DANTIS L
SKLARIN NT
SEIDMAN AD
HUDIS CA
MOORE J
ROSEN PP
TWADDELL T
HENDERSON IC
NORTON L
Citation: J. Baselga et al., PHASE-II STUDY OF WEEKLY INTRAVENOUS RECOMBINANT HUMANIZED ANTI-P185(HER2) MONOCLONAL-ANTIBODY IN PATIENTS WITH HER2 NEU-OVEREXPRESSING METASTATIC BREAST/, Journal of clinical oncology, 14(3), 1996, pp. 737-744
Authors:
DILORENZO TA
JACOBSEN PB
BOVBJERG DH
CHANG H
HUDIS CA
SKLARIN NT
NORTON L
Citation: Ta. Dilorenzo et al., SOURCES OF ANTICIPATORY EMOTIONAL DISTRESS IN WOMEN RECEIVING CHEMOTHERAPY FOR BREAST-CANCER, Annals of oncology, 6(7), 1995, pp. 705-711
Citation: Nt. Sklarin et M. Markham, SPONTANEOUS RECURRENT TUMOR LYSIS SYNDROME IN BREAST-CANCER, American journal of clinical oncology, 18(1), 1995, pp. 71-73
Authors:
WIERNIK PH
SKLARIN NT
DUTCHER JP
SPARANO JA
GREENWALD ES
Citation: Ph. Wiernik et al., ADJUVANT RADIOTHERAPY FOR BREAST-CANCER AS A RISK FACTOR FOR THE DEVELOPMENT OF LUNG-CANCER, Medical oncology, 11(3-4), 1994, pp. 121-125
Citation: Rn. Pollack et al., METASTATIC PLACENTAL LYMPHOMA ASSOCIATED WITH MATERNAL HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Obstetrics and gynecology, 81(5), 1993, pp. 856-857